2 active not recruiting. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Active not recruiting 2 |
Follow Obstructive Sleep Apnea: new trials by email Literature Review of Obstructive Sleep Apnea trials Research Report on Obstructive Sleep Apnea
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy Maridebart cafraglutide, Placebo - Obesity, Obstructive Sleep Apnea | Phase 3 | Active not recruiting | Amgen | 250 | 2025-12-19 | 2026-10-06 |
| Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) Therapy Maridebart cafraglutide, Placebo - Obstructive Sleep Apnea | Phase 3 | Active not recruiting | Amgen | 250 | 2025-11-25 | 2026-09-29 |
Obesity (2) · Sleep Apnea, Obstructive (2) · Overweight (1)
Apnea (2) · Body Weight (2) · Dyssomnias (2) · Nervous System Diseases (2) · Nutrition Disorders (2) · Nutritional and Metabolic Diseases (2) · Overnutrition (2) · Pathological Conditions, Signs and Symptoms (2) · Respiration Disorders (2) · Respiratory Tract Diseases (2) · Signs and Symptoms (2) · Sleep Apnea Syndromes (2) · Sleep Disorders, Intrinsic (2) · Sleep Wake Disorders (2) · Overweight (1)
Amgen (2)
Australia (2) · Brazil (2) · Canada (2) · Czechia (2) · France (2) · Germany (2) · Hungary (2) · Japan (2) · Poland (2) · Spain (2) · United States (2)